resources

Shelter Pharma Ltd.

BSE: 543963

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

26.90-0.1 (-0.37%)

24 Jul, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Shelter Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2024	2025	2026
Annual Reports	FY 2024	FY 2025	—
Quarterly Results	—	Sept	Mar
Conference Calls	—	—	27Jun
Presentations	—	—	17Jun

Corporate Announcements and Regulatory Filings

Shelter Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Award of Order / Receipt of Order24 Jul 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015-Receipt Order from Verka Dairy Ludhiana.
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201814 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026.
Award of Order / Receipt of Order10 Jul 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Intimation under Regulation 30 of SEBI (LODR) Regulation 2015- Receipt of Significant International Purchase Orders.
General1 Jul 2026
Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-
Intimation Under Regulaation 30 of SEBI LODR (Regulation) 2015- Completion and Successful Dispatch of Export Order.
Analyst / Investor Meet20 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Submission of Video Recording of H2 & FY2026 Investor Conference Call.
General16 Jun 2026
Corrigendum To Intimation Of H2 FY2026 Investor Conference Call
Corrigendum to intimation of H2 FY2026 Investor Conference Call
Analyst / Investor Meet15 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of shelter pharma limited- Company H2 FY2026 Investor Call.
General8 Jun 2026
Corrigendum To Intimation Of H2 FY2026 Investor Conference Call Withdrawal Of Scheduled Meeting
Corrigendum to intimation of H2 FY2026 Investor Conference Call- Withdrawal of Scheduled Meeting
General8 Jun 2026
Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015-
Intimation Under Regulation 30 of SEBI LODR (Regulation) 2015- Completion and commencement of Dispatch of Export Order.
Analyst / Investor Meet5 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of shelter pharma limited Company H2 FY2026-Investor Call.
General3 Jun 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015- Receipt Of Good Manufacturing Practices Certificate
Initimation under Regulation 30 of SEBI (LODR) Regulations 2015- Receipt of Good Manufacturing Practices Certificate
General2 Jun 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015-Receipt Of Renewal Manufacturing Licence
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- Receipt of Renewal Manufacturing Licence
General28 May 2026
Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Statement of Deviation or Variation pursuant to Regulation 32 of SEBI ( Listing Obligations and Disclosure Requirements) Regulatioms 2015
Change in Management28 May 2026
Announcement under Regulation 30 (LODR)-Change in Management
Outcome of the board meeting and submission of the audited standalone finaacial results for the half year and year ended march 31, 2026 and appointment of internal auditor.
Outcome of Board Meeting28 May 2026
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And
Outcome of the Board Meeting and Submission of the Audited Standalone Financial Results for the Half year and year ended March 31, 2026.
Board Meeting22 May 2026
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 28Th May, 2026
Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
General19 May 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015-Continuous Positive Customer Feedback On Company Products
Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015- Continuous Positive Customer Feedback on Company Products.
General18 May 2026
Intimation Under Regulation 30 Of SEBI ( LODR ) Regulations 2015 - Participation In Iphex 2026 International Pharmaceutical Exihibition
Intimation under Regulation 30 of SEBI ( LODR ) Regulation 2015 - Participation in iPHEX 2026 International Pharmaceutical Exihibition
Award of Order / Receipt of Order15 May 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- Receipt Work Order pursuant to Tender Process.
General13 May 2026
Intimation Under Regulation 30 For Successfully Conducted A CME Programme In Patna Bihar On 11Th May 2026
Intimation under Regulation 30 for Successfully Conducted a CME Programme in Patna Bihar on 11th May 2026

Frequently Asked Questions

Where can I download the annual report of Shelter Pharma Ltd.?

Annual reports of Shelter Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Shelter Pharma Ltd.?

Quarterly earnings results and presentations of Shelter Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Shelter Pharma Ltd. publish earnings call transcripts?

Earnings call transcripts of Shelter Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Shelter Pharma Ltd.?

Investor presentations and annual day presentations of Shelter Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Shelter Pharma Ltd.?

Corporate announcements and regulatory filings of Shelter Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Shelter Pharma Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Shelter Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Shelter Pharma Ltd.?

The ISIN (International Securities Identification Number) of Shelter Pharma Ltd. is INE013V01011. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Shelter Pharma Ltd. listed?

Shelter Pharma Ltd. is listed on NSE and BSE. The NSE symbol is 543963-BOM and the BSE code is -.

Where can I find the shareholding pattern of Shelter Pharma Ltd.?

The quarterly shareholding pattern of Shelter Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Shelter Pharma Ltd. on Sharpely?

Share price data for Shelter Pharma Ltd. is updated as of 24 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.